.After antibody-drug conjugate (ADC) professional Seagen was marketed to Pfizer in 2013 for a monstr...
.On the heels of a stage 3 succeed that stopped working to blow away clients, Ironwood Pharmaceutica...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is actually having a ball after auth...
.Invite to this week's Chutes & Ladders, our roundup of notable leadership hirings, shootings as ...
.Celebrating his company's upsized initial public offering (IPO), Septerna chief executive officer J...
.AbbVie has actually come back to the source of its antipsychotic powerhouse Vraylar trying to find ...
.GenSight Biologics is actually full weeks away from losing loan. Once more. The biotech simply poss...
.Monopar Therapies is actually recovering a medication coming from the dump of AstraZeneca's uncommo...
.Along with new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of prof...
.After creating a genetics treatment partnership with Dyno Therapeutics in 2020, Roche is back for a...